RecruitingNot applicableNCT06814171
UBC Breakfast Study 2.0
Studying Disorder of carbohydrate metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of British Columbia
- Intervention
- Low-carbohydrate breakfast(other)
- Enrollment
- 280 target
- Eligibility
- 30-79 years · All sexes
- Timeline
- 2025 – 2027
Study locations (1)
- University of British Columbia - Okanagan, Kelowna, British Columbia, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06814171 on ClinicalTrials.govOther trials for Disorder of carbohydrate metabolism
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07420998Effect of a Nutritional Product Containing Carob Extract on Carbohydrate Metabolism in Glucose-intolerant SubjectsUniversidad Católica San Antonio de Murcia
- RECRUITINGNCT07160816A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood SugarNovo Nordisk A/S
- RECRUITINGPHASE3NCT07076199A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesNovo Nordisk A/S
- RECRUITINGNANCT07150052Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes MellitusUniversity of Sao Paulo
- ACTIVE NOT RECRUITINGPHASE3NCT06747468Avexitide for Treatment of Post-Bariatric HypoglycemiaAmylyx Pharmaceuticals Inc.
- RECRUITINGNANCT06837376Effects of Metabolic Testing Data and Education on Attitudes and Beliefs Related to Carbohydrate Intake in Adolescent Female AthletesPepsiCo Global R&D
- RECRUITINGNANCT06614101Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled AirUniversity Hospital, Toulouse
- RECRUITINGNANCT06700915A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and MetabolismUltimate International, Inc.